Engineering a potent boron-10-enriched polymeric nanoparticle for boron neutron capture therapy - supporting information
Background: Boron neutron capture therapy (BNCT) is a promising cancer treatment that eliminates
tumor cells by triggering high-energy radiation within cancer cells. Aim: In vivo evaluation of poly(vinyl
alcohol)/boric acid crosslinked nanoparticles (PVA/BA NPs) for BNCT. Materials & methods: PVA/BA NPs
were synthesized and intravenously injected into tumor-bearingmice for BNCT. Results: The in vitro boron
uptake of PVA/BA NPs in tumor cells was 70-fold higher than the required boron uptake for successful
BNCT. In an in vivo study, PVA/BA NPs showed a 44.29% reduction in tumor size compared with clinically
used boronophenylalanine for oral cancer in a murine model. Conclusion: PVA/BA NPs exhibited effective
therapeutic results for oral cancer treatments in BNCT.